Suppr超能文献

抗体介导的拉沙病毒中和作用的结构基础。

Structural basis for antibody-mediated neutralization of Lassa virus.

作者信息

Hastie Kathryn M, Zandonatti Michelle A, Kleinfelter Lara M, Heinrich Megan L, Rowland Megan M, Chandran Kartik, Branco Luis M, Robinson James E, Garry Robert F, Saphire Erica Ollmann

机构信息

Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.

出版信息

Science. 2017 Jun 2;356(6341):923-928. doi: 10.1126/science.aam7260.

Abstract

The arenavirus Lassa causes severe hemorrhagic fever and a significant disease burden in West Africa every year. The glycoprotein, GPC, is the sole antigen expressed on the viral surface and the critical target for antibody-mediated neutralization. Here we present the crystal structure of the trimeric, prefusion ectodomain of Lassa GP bound to a neutralizing antibody from a human survivor at 3.2-angstrom resolution. The antibody extensively anchors two monomers together at the base of the trimer, and biochemical analysis suggests that it neutralizes by inhibiting conformational changes required for entry. This work illuminates pH-driven conformational changes in both receptor-binding and fusion subunits of Lassa virus, illustrates the unique assembly of the arenavirus glycoprotein spike, and provides a much-needed template for vaccine design against these threats to global health.

摘要

沙粒病毒拉沙病毒每年在西非引发严重出血热并造成重大疾病负担。糖蛋白GPC是病毒表面表达的唯一抗原,也是抗体介导中和作用的关键靶点。在此,我们展示了与一名人类幸存者的中和抗体结合的拉沙病毒糖蛋白三聚体前融合胞外域的晶体结构,分辨率为3.2埃。该抗体在三聚体底部将两个单体广泛地锚定在一起,生化分析表明它通过抑制病毒进入所需的构象变化来实现中和作用。这项工作阐明了拉沙病毒受体结合亚基和融合亚基中由pH驱动的构象变化,展示了沙粒病毒糖蛋白刺突的独特组装方式,并为针对这些全球健康威胁设计疫苗提供了急需的模板。

相似文献

1
Structural basis for antibody-mediated neutralization of Lassa virus.
Science. 2017 Jun 2;356(6341):923-928. doi: 10.1126/science.aam7260.
2
3
Lassa virus glycoprotein: stopping a moving target.
Curr Opin Virol. 2018 Aug;31:52-58. doi: 10.1016/j.coviro.2018.05.002. Epub 2018 May 26.
4
Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies.
Cell Rep. 2022 May 24;39(8):110841. doi: 10.1016/j.celrep.2022.110841.
7
Molecular Mechanism for LAMP1 Recognition by Lassa Virus.
J Virol. 2015 Aug;89(15):7584-92. doi: 10.1128/JVI.00651-15. Epub 2015 May 13.
8
Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies.
Cell Rep. 2023 May 30;42(5):112524. doi: 10.1016/j.celrep.2023.112524. Epub 2023 May 18.
9
Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5.
J Virol. 2017 Jul 27;91(16). doi: 10.1128/JVI.00134-17. Print 2017 Aug 15.
10
Structure of the Lassa virus glycan shield provides a model for immunological resistance.
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7320-7325. doi: 10.1073/pnas.1803990115. Epub 2018 Jun 25.

引用本文的文献

1
Molecular organization of the New World arenavirus spike glycoprotein complex.
Nat Microbiol. 2025 Aug 8. doi: 10.1038/s41564-025-02085-6.
2
The Biological Characteristics and Mouse Model of Lassa Virus From the First Imported Case in China.
MedComm (2020). 2025 Aug 3;6(8):e70315. doi: 10.1002/mco2.70315. eCollection 2025 Aug.
3
Metal-induced conformational changes in the Sabiá virus spike complex.
Nat Microbiol. 2025 Aug 1. doi: 10.1038/s41564-025-02075-8.
4
Infusion of neutralization into Lassa vaccine design.
Trends Immunol. 2025 Jul;46(7):512-524. doi: 10.1016/j.it.2025.05.006. Epub 2025 Jun 24.
5
NMR side-chain assignments of the Crimean-Congo hemorrhagic fever virus glycoprotein n cytosolic domain.
Magn Reson (Gott). 2024 Jul 8;5(2):95-101. doi: 10.5194/mr-5-95-2024. eCollection 2024.
8
In danger: HIV vaccine research and development in Europe.
PLOS Glob Public Health. 2025 Apr 8;5(4):e0004364. doi: 10.1371/journal.pgph.0004364. eCollection 2025.
9
Mapping the antibody response to Lassa virus vaccination of non-human primates.
EBioMedicine. 2025 Apr;114:105673. doi: 10.1016/j.ebiom.2025.105673. Epub 2025 Mar 31.

本文引用的文献

1
Role of LAMP1 Binding and pH Sensing by the Spike Complex of Lassa Virus.
J Virol. 2016 Oct 28;90(22):10329-10338. doi: 10.1128/JVI.01624-16. Print 2016 Nov 15.
2
Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies.
Antiviral Res. 2016 Sep;133:218-222. doi: 10.1016/j.antiviral.2016.08.012. Epub 2016 Aug 13.
3
Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV.
Nat Struct Mol Biol. 2016 Sep;23(9):811-820. doi: 10.1038/nsmb.3267. Epub 2016 Aug 1.
5
Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis.
J Virol. 2016 Jun 24;90(14):6412-6429. doi: 10.1128/JVI.00257-16. Print 2016 Jul 15.
6
Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV.
Nat Struct Mol Biol. 2016 Jun;23(6):513-521. doi: 10.1038/nsmb.3210. Epub 2016 Apr 25.
7
Acidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike.
PLoS Pathog. 2016 Feb 5;12(2):e1005418. doi: 10.1371/journal.ppat.1005418. eCollection 2016 Feb.
8
Molecular Basis for Antibody-Mediated Neutralization of New World Hemorrhagic Fever Mammarenaviruses.
Cell Host Microbe. 2015 Dec 9;18(6):705-13. doi: 10.1016/j.chom.2015.11.005.
9
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.
PLoS Pathog. 2015 Nov 20;11(11):e1005276. doi: 10.1371/journal.ppat.1005276. eCollection 2015 Nov.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验